The hallucinogenic world of tryptamines: an updated review
- PMID: 25877327
- DOI: 10.1007/s00204-015-1513-x
The hallucinogenic world of tryptamines: an updated review
Abstract
In the area of psychotropic drugs, tryptamines are known to be a broad class of classical or serotonergic hallucinogens. These drugs are capable of producing profound changes in sensory perception, mood and thought in humans and act primarily as agonists of the 5-HT2A receptor. Well-known tryptamines such as psilocybin contained in Aztec sacred mushrooms and N,N-dimethyltryptamine (DMT), present in South American psychoactive beverage ayahuasca, have been restrictedly used since ancient times in sociocultural and ritual contexts. However, with the discovery of hallucinogenic properties of lysergic acid diethylamide (LSD) in mid-1900s, tryptamines began to be used recreationally among young people. More recently, new synthetically produced tryptamine hallucinogens, such as alpha-methyltryptamine (AMT), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), emerged in the recreational drug market, which have been claimed as the next-generation designer drugs to replace LSD ('legal' alternatives to LSD). Tryptamine derivatives are widely accessible over the Internet through companies selling them as 'research chemicals', but can also be sold in 'headshops' and street dealers. Reports of intoxication and deaths related to the use of new tryptamines have been described over the last years, raising international concern over tryptamines. However, the lack of literature pertaining to pharmacological and toxicological properties of new tryptamine hallucinogens hampers the assessment of their actual potential harm to general public health. This review provides a comprehensive update on tryptamine hallucinogens, concerning their historical background, prevalence, patterns of use and legal status, chemistry, toxicokinetics, toxicodynamics and their physiological and toxicological effects on animals and humans.
Similar articles
-
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.Eur Neuropsychopharmacol. 2016 Aug;26(8):1327-37. doi: 10.1016/j.euroneuro.2016.05.001. Epub 2016 May 20. Eur Neuropsychopharmacol. 2016. PMID: 27216487
-
Abuse liability profile of three substituted tryptamines.J Pharmacol Exp Ther. 2011 Jul;338(1):280-9. doi: 10.1124/jpet.111.179705. Epub 2011 Apr 7. J Pharmacol Exp Ther. 2011. PMID: 21474568 Free PMC article.
-
Clinical toxicology of newer recreational drugs.Clin Toxicol (Phila). 2011 Oct;49(8):705-19. doi: 10.3109/15563650.2011.615318. Clin Toxicol (Phila). 2011. PMID: 21970769 Review.
-
The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.Psychopharmacology (Berl). 2015 Jan;232(1):275-84. doi: 10.1007/s00213-014-3658-3. Epub 2014 Jul 3. Psychopharmacology (Berl). 2015. PMID: 24985890 Free PMC article.
-
Toxicology and Analysis of Psychoactive Tryptamines.Int J Mol Sci. 2020 Dec 4;21(23):9279. doi: 10.3390/ijms21239279. Int J Mol Sci. 2020. PMID: 33291798 Free PMC article. Review.
Cited by
-
Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties.Mol Psychiatry. 2024 Mar 14. doi: 10.1038/s41380-024-02506-8. Online ahead of print. Mol Psychiatry. 2024. PMID: 38486047
-
Effects of hallucinogenic drugs on the human heart.Front Pharmacol. 2024 Feb 2;15:1334218. doi: 10.3389/fphar.2024.1334218. eCollection 2024. Front Pharmacol. 2024. PMID: 38370480 Free PMC article. Review.
-
Potential of Tryptamine Derivatives as Multi-Target Directed Ligands for Alzheimer's Disease: AChE, MAO-B, and COX-2 as Molecular Targets.Molecules. 2024 Jan 19;29(2):490. doi: 10.3390/molecules29020490. Molecules. 2024. PMID: 38276568 Free PMC article.
-
Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice-from a human poisoning case to the preclinical evidence.Psychopharmacology (Berl). 2024 Mar;241(3):489-511. doi: 10.1007/s00213-024-06526-8. Epub 2024 Jan 12. Psychopharmacology (Berl). 2024. PMID: 38214743 Free PMC article.
-
Molecular and Medical Aspects of Psychedelics.Int J Mol Sci. 2023 Dec 23;25(1):241. doi: 10.3390/ijms25010241. Int J Mol Sci. 2023. PMID: 38203411 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources